Ferozsons Laboratories (KAR:FEROZ) Cyclically Adjusted FCF per Share: ₨-14.60 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:FEROZ Ferozsons Laboratories Ltd KAR:FEROZ
70 GF Score
Price ₨374.69
GF Value ₨427.31
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ferozsons Laboratories Cyclically Adjusted FCF per Share?

Ferozsons Laboratories KAR:FEROZ -0.50% 70 Cyclically Adjusted FCF per Share is ₨-14.60 as of Mar. 2026. GuruFocus rates KAR:FEROZ with a GF Score™ of 70/100 and a GF Value™ of ₨427.31 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ferozsons Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2026 was ₨-41.443. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₨-14.60 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-16), Ferozsons Laboratories's current stock price is ₨374.69. Ferozsons Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ₨-14.60. Ferozsons Laboratories's Cyclically Adjusted Price-to-FCF of today is .


Ferozsons Laboratories  (KAR:FEROZ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ferozsons Laboratories Cyclically Adjusted FCF per Share Related Terms


Ferozsons Laboratories Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Ferozsons Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ferozsons Laboratories Cyclically Adjusted FCF per Share Chart

Ferozsons Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -8.32 -8.95

Ferozsons Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.77 -8.95 -9.68 -9.44 -14.60

KAR:FEROZ vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ferozsons Laboratories Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ferozsons Laboratories's Cyclically Adjusted Price-to-FCF falls into.


KAR:FEROZ
70GF Score
Ferozsons Laboratories Ltd KAR:FEROZ
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ferozsons Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ferozsons Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-41.443/330.2130*330.2130
=-41.443

Current CPI (Mar. 2026) = 330.2130.

Ferozsons Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -26.484 241.018 -36.285
201609 1.778 241.428 2.432
201612 -3.466 241.432 -4.741
201703 -0.667 243.801 -0.903
201706 12.860 244.955 17.336
201709 -2.684 246.819 -3.591
201712 -1.925 246.524 -2.578
201803 -0.715 249.554 -0.946
201806 9.818 251.989 12.866
201809 -9.562 252.439 -12.508
201812 -3.424 251.233 -4.500
201903 3.484 254.202 4.526
201906 10.519 256.143 13.561
201909 -7.129 256.759 -9.168
201912 -5.028 256.974 -6.461
202003 1.120 258.115 1.433
202006 3.490 257.797 4.470
202009 -12.987 260.280 -16.476
202012 22.350 260.474 28.334
202103 5.919 264.877 7.379
202106 -1.246 271.696 -1.514
202109 2.458 274.310 2.959
202112 -12.243 278.802 -14.501
202203 -1.735 287.504 -1.993
202206 -21.996 296.311 -24.513
202209 -24.931 296.808 -27.737
202212 -21.662 296.797 -24.101
202303 -8.970 301.836 -9.813
202306 -10.399 305.109 -11.255
202309 0.338 307.789 0.363
202312 -28.291 306.746 -30.455
202403 -18.751 312.332 -19.824
202406 20.529 314.175 21.577
202409 1.357 315.301 1.421
202412 12.343 315.605 12.914
202503 -1.564 319.799 -1.615
202506 5.501 322.561 5.631
202509 16.569 324.800 16.845
202512 6.783 324.054 6.912
202603 -41.443 330.213 -41.443

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ₨-14.60 mean?
Ferozsons Laboratories (KAR:FEROZ) has a Cyclically Adjusted FCF per Share of ₨-14.60 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ferozsons Laboratories and its competitors.
Is Ferozsons Laboratories' Cyclically Adjusted FCF per Share too high?
Ferozsons Laboratories' current Cyclically Adjusted FCF per Share is ₨-14.60. Overall, Ferozsons Laboratories has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ferozsons Laboratories' Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Ferozsons Laboratories' Cyclically Adjusted FCF per Share of ₨-14.60 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ferozsons Laboratories and its competitors. Ferozsons Laboratories's current Cyclically Adjusted FCF per Share is ₨-14.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ferozsons Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ferozsons Laboratories (KAR:FEROZ) is currently considered Modestly Undervalued. The stock's GF Value™ is ₨427.31, compared to a current price of ₨374.69 — trading 12.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ₨-14.60. Ferozsons Laboratories' overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Ferozsons Laboratories (KAR:FEROZ), the current Cyclically Adjusted FCF per Share is ₨-14.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued. The current stock price of ₨374.69 is trading 12.3% below its estimated GF Value™ of ₨427.31. GuruFocus considers Ferozsons Laboratories to be Modestly Undervalued.

Key valuation signals for KAR:FEROZ:

  • Cyclically Adjusted FCF per Share: ₨-14.60
  • GF Value™: ₨427.31 vs. price of ₨374.69 (12.3% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ferozsons Laboratories Business Description

Address 5 K.M Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
70GF Score

Get the complete analysis for KAR:FEROZ

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨374.69
Price
₨427.31
GF Value